Marginal periodontitis: its treatment with topical and systemic agents. A review of the literature, part I. 1984

P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour

UI MeSH Term Description Entries
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D010518 Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) Pericementitis,Pericementitides,Periodontitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
D049673 History, 20th Century Time period from 1901 through 2000 of the common era. 20th Century History,20th Cent. History (Medicine),20th Cent. History of Medicine,20th Cent. Medicine,Historical Events, 20th Century,History of Medicine, 20th Cent.,History, Twentieth Century,Medical History, 20th Cent.,Medicine, 20th Cent.,20th Cent. Histories (Medicine),20th Century Histories,Cent. Histories, 20th (Medicine),Cent. History, 20th (Medicine),Century Histories, 20th,Century Histories, Twentieth,Century History, 20th,Century History, Twentieth,Histories, 20th Cent. (Medicine),Histories, 20th Century,Histories, Twentieth Century,History, 20th Cent. (Medicine),Twentieth Century Histories,Twentieth Century History
D049690 History, Ancient The period of history before 500 of the common era. Ancient History,Ancient History (Medicine),Ancient History of Medicine,History of Medicine, Ancient,Medicine, Ancient History,Ancient Histories (Medicine),Ancient History Medicine,Ancient History Medicines,Histories, Ancient (Medicine),History Medicine, Ancient,History Medicines, Ancient,History, Ancient (Medicine),Medicine Ancient History,Medicines, Ancient History
D049691 History, Medieval The period of history from the year 500 through 1450 of the common era. Medieval History,History of Medicine, Medieval,History of Medicine, Renaissance,Medicine, Medieval History,Medicine, Renaissance,Medieval History (Medicine),Renaissance Medicine,Histories, Medieval (Medicine),History Medicine, Medieval,History, Medieval (Medicine),Medieval Histories (Medicine),Medieval History Medicine
D049711 History, Modern 1601- The period of history from 1601 of the common era to the present. History, Modern,Modern History,History of Medicine, Modern,Medicine, Modern,Modern History (Medicine),Modern Medicine,1601- History, Modern,History, Modern (Medicine),History, Modern 1601,Modern 1601- History

Related Publications

P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
May 1968, BZB. Bayerisches Zahnarzteblatt,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
November 1993, Journal of periodontology,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
January 1986, Archivos de odonto estomatologia,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
October 2012, Journal of Indian Society of Periodontology,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
January 1979, Mississippi Dental Association journal,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
December 1994, The European journal of prosthodontics and restorative dentistry,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
October 2023, Current problems in cardiology,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
June 2009, Fogorvosi szemle,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
December 2017, Journal of drugs in dermatology : JDD,
P J Heins, and S Low, and F Collins, and C F Rau, and M Manouchehr-Pour
November 2013, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!